The relationship between expression of adeABC and minimal inhibitory concentration (MIC) of tigecycline was investigated by RT-PCR and statistical analyses in a population of 106 clinical isolates (MIC range, 0.0313–16 μg/ml) of Acinetobacter calcoaceticus–Acinetobacter baumannii complex. There was a statistically significant linear relationship (p < 0.0001) between log-transformed expression values and log-transformed MIC values, indicating that overexpression of AdeABC efflux pump is a prevalent mechanism for decreased susceptibility to tigecycline in A. calcoaceticus–A. baumannii complex.
Get full access to this article
View all access options for this article.
References
1.
ChauS.L., ChuY.W., HouangE.T.2004. Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3. Antimicrob. Agents Chemother., 48:4054–4055.
2.
CLSI. 2009. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard M07-A8. Eighth. Clinical Laboratory Standards Institute: Wayne, PA.
Damier-PiolleL., MagnetS., BremontS., LambertT., CourvalinP.2008. AdeIJK, a RND pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob. Agents Chemother., 52:557–562
5.
DeanC.R., VisalliM.A., ProjanS.J., SumP.-E., BradfordP.A.2003. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob. Agents Chemother., 47:972–978.
6.
HigginsP.G., WisplinghoffH., StefanikD., SeifertH.2004. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. J. Antimicrob. Chemother., 54:821–823.
7.
KeeneyD., RuzinA., BradfordP.A.2006. RamA, a transcriptional regulator, and AcrAB, a RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb. Drug Resist., 13:1–6
8.
KeeneyD., RuzinA., McAleeseF., MurphyE., BradfordP.A.2008. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J. Antimicrob. Chemother., 61:46–53.
9.
MagnetS., CourvalinP., LambertT.2001. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother., 45:3375–3380.
10.
MarchandI., Damier-PiolleL., CourvalinP., LambertT.2004. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob. Agents Chemother., 48:3298–3304.
11.
NemecA., MaixnerovaM., van der ReijdenT.J., van den BroekP.J., DijkshoornL.2007. Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains. J. Antimicrob. Chemother., 60:483–489.
12.
PelegA.Y., AdamsJ., PatersonD.L.2007. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii. Antimicrob. Agents Chemother., 51:2065–2069.
13.
PetersenP.J., JacobusN.V., WeissW.J., SumP.E., TestaR.T.1999. In vitro and in vivo antimicrobial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936)Antimicrob. Agents Chemother., 43:738–744.
14.
RuzinA., KeeneyD., BradfordP.A.2005. AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob. Agents Chemother., 49:791–793.
15.
RuzinA., KeeneyD., BradfordP.A.2007. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J. Antimicrob. Chemother., 59:1001–1004.
16.
SuX.Z., ChenJ., MizushimaT., KurodaT., TsuchiyaT.2005. AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob. Agents Chemother., 49:4362–4364.
17.
VisalliM.A., MurphyE., ProjanS.J., BradfordP.A.2003. AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis. Antimicrob. Agents Chemother., 47:665–669.
